Wang H et al.Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1.Sci Rep 8:7080 (2018).
Wu X et al.The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.PLoS Genet 14:e1007366 (2018).
Khalaj K et al.RNA binding protein, tristetraprolin in a murine model of recurrent pregnancy loss.Oncotarget 7:72486-72502 (2016).
Deng K et al.Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.Sci Rep 6:24505 (2016).
Blanco FF et al.Transforming growth factor ß regulates P-body formation through induction of the mRNA decay factor tristetraprolin.Mol Cell Biol 34:180-95 (2014).
Chowdhury S et al.IL-17 Attenuates Degradation of ARE-mRNAs by Changing the Cooperation between AU-Binding Proteins and microRNA16.PLoS Genet 9:e1003747 (2013).
Shi JX et al.MK2 post-transcriptionally regulates TNF-a-induced expression of ICAM-1 and IL-8 via tristetraprolin in human pulmonary microvascular endothelial cells.Am J Physiol Lung Cell Mol Physiol : (2012).
Ness GC et al.Involvement of tristetraprolin in transcriptional activation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin.Biochem Biophys Res Commun 420:178-82 (2012).
Masuda K et al.Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation.Aging (Albany NY) 1:681-98 (2009).